**Core Concept**
The ABVD regimen is a chemotherapy protocol used for the treatment of Hodgkin's lymphoma, not Non-Hodgkin's lymphoma. It consists of a combination of drugs that target rapidly dividing cancer cells. The drugs in the ABVD regimen work by inhibiting DNA synthesis, disrupting cell division, and inducing apoptosis.

**Why the Correct Answer is Right**
The ABVD regimen includes Adriamycin (doxorubicin), Bleomycin, Vinblastine, and Dacarbazine. These drugs work synergistically to kill cancer cells. Adriamycin and Dacarbazine are alkylating agents that cross-link DNA, causing cell death. Bleomycin is a DNA-binding agent that causes strand breaks, leading to cell death. Vinblastine is a vinca alkaloid that inhibits microtubule formation, preventing cell division.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely to be incorrect because the ABVD regimen is specifically used for Hodgkin's lymphoma, not Non-Hodgkin's lymphoma. However, without knowing the actual options, it's difficult to provide a specific explanation.

**Clinical Pearl / High-Yield Fact**
The ABVD regimen is a key treatment protocol for Hodgkin's lymphoma, and its effectiveness is well-established. However, it's essential to note that the treatment of Non-Hodgkin's lymphoma typically involves different chemotherapy regimens, such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone).

**Correct Answer:**
Unfortunately, the question does not include the actual options. Please provide the options, and I'll be happy to complete the explanation.